Search the Newsreel

Verastem, Inc. (VSTM) sees 7.76% ownership reported by Armistice Capital

Armistice Capital, LLC and Steven Boyd have reported a significant beneficial ownership stake of 7.76% in Verastem, Inc. (VSTM), totaling 7,024,000 shares. This ownership is held with shared voting and dispositive power through Armistice Capital Master Fund Ltd., where Armistice Capital acts as the …

HC Wainwright Has Negative Estimate for Erasca Q3 Earnings

Is It Worth Considering Jerash Holdings (US), Inc. (NASDAQ:JRSH) For Its Upcoming Dividend?

Jerash Holdings (US), Inc. (NASDAQ:JRSH) is set to trade ex-dividend soon, offering a US$0.05 per share payment, contributing to a 3.8% trailing yield. The company's dividend appears sustainable, with payouts covered by 52% of profit and 38% of free cash flow. However, flat earnings …

Erasca, Inc. (NASDAQ:ERAS) Receives Average Rating of "Moderate Buy" from Brokerages

Erasca, Inc. (NASDAQ:ERAS) has received a "Moderate Buy" consensus rating from eleven brokerages, with an average 12-month price target of $21.91. Despite a recent 3.9% decline in shares and missing analyst expectations for its quarterly loss, institutional investors hold a significant 67.78% of the …

Jerash Holdings To Go Ex-Dividend On August 17th, 2026 With 0.05 USD Dividend Per Share

Jerash Holdings (NASDAQ: JRSH) has announced that it will go ex-dividend on August 17th, 2026. Shareholders will receive a dividend of $0.05 per share. Investors must own shares before the ex-dividend date to be eligible for the payment.

Verastem (VSTM) Q2 2026 Earnings Call Transcript

Verastem (VSTM) reported strong Q2 2026 results, with net product revenue of $25.1 million and total revenue of $40.1 million. The company secured $75 million in non-dilutive royalty financing and a $15 million milestone payment, extending its cash runway into the second half of …

Guggenheim raises Erasca stock price target to $21 on pipeline progress

Guggenheim has increased its price target for Erasca Inc. (NASDAQ: ERAS) to $21 from $20, maintaining a Buy rating, citing confidence in the company's RAS inhibitor pipeline progress. This follows Erasca's second-quarter 2026 results and a pipeline update, including advanced development plans for ERAS-0015 …

Peraso Shrinks the Hardware Behind Faster Drone Comms

Peraso Inc. has introduced the PRM2145, a new lightweight module designed to enhance drone communications. This module utilizes 60-gigahertz millimeter-wave (mmWave) technology to provide secure, low-latency data transfer while minimizing power consumption and weight. The technology aims to improve command-and-control links, support high-definition video, …

Jerash Holdings (US), Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Jerash Holdings (US), Inc. recently surpassed analyst expectations with strong quarterly results, reporting higher-than-estimated revenue and earnings per share. Following this performance, analysts have increased their revenue and EPS forecasts for 2027 and raised the consensus price target to US$6.50, indicating improved sentiment and …

Jerash Holdings (US), Inc. Q2 2026: Revenue $50.23M, EPS $0.13— 10-Q Summary

Jerash Holdings (US), Inc. reported strong second-quarter 2026 results, with revenue increasing 27% year-over-year to $50.23 million and diluted EPS rising to $0.13 from $0.03. The growth was attributed to increased shipments to major U.S. buyers and new customer acquisitions, which also improved profitability. …

Earnings call transcript: Peraso posts q2 2026 miss, shares jump after hours

Peraso Inc. reported a wider-than-expected loss and lower revenue for Q2 2026, missing analyst estimates. However, shares rose after hours due to sequential growth, improved gross margins, and a growing defense pipeline, particularly with the introduction of a new jam-resistant module for unmanned systems. …

Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers

Propanc Biopharma, Inc. Contrasting Science with Revolution Medicines and Erasca MELBOURNE, Australia, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) ("Propanc" or the "Company"), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today …

Hennion & Walsh Asset Management Inc. Acquires 347,872 Shares of Verastem, Inc. $VSTM

Hennion & Walsh Asset Management Inc. significantly increased its stake in Verastem, Inc. (NASDAQ:VSTM) by 157.2%, acquiring an additional 347,872 shares, bringing their total ownership to 569,195 shares valued at $2.17 million. This move is part of broader institutional interest, with collective institutional ownership …

Peraso Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:PRSO) 2026-08-12

Peraso Inc. (PRSO) published its Q2 2026 earnings call presentation on August 12, 2026. This slide deck accompanies the company's financial results for the second quarter of 2026. The information was released by SA Transcripts, which covers thousands of quarterly earnings calls.

Form 8K Peraso Inc For: 11 August By Investing.com

This article reports that Peraso Inc. filed a Form 8K on August 11. The filing is a standard regulatory announcement for significant events that shareholders should know about. The brief piece includes the company's stock symbol, PRSO.

Peraso (NASDAQ: PRSO) Amid AUUD, SCKT, ACHR Launches Jam-Resistant Military Drone Module Ahead of Earnings

Peraso Inc. (NASDAQ: PRSO) has introduced a new jam-resistant 60GHz millimeter-wave communications module, the PRM2145, for military drones and other autonomous systems, expanding its market presence in defense communications. This module is designed for secure, low-latency gigabit communications with enhanced resistance to jamming. The …

Peraso (PRSO) Reports Q2 Loss, Tops Revenue Estimates

Peraso (PRSO) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.28 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report …

Erasca (NASDAQ:ERAS) Announces Earnings Results, Misses Expectations By $0.03 EPS

Peraso earnings missed by $0.02, revenue fell short of estimates

ERAS: ERAS-0015 delivers strong efficacy and safety in RAS-mutant cancers, advancing toward pivotal trials

ERAS-0015 is showing strong efficacy and safety in treating RAS-mutant cancers, including NSCLC and PDAC, with high response rates. The company has a robust pipeline targeting RAS/MAPK-driven cancers and strong financial backing to support upcoming pivotal trials. This positions ERAS as a potential leader …

Erasca (ERAS) boosts cash by $836M while advancing RAS oncology pipeline

Peraso Revenue Climbs About 36% After Delayed Order Ships

Peraso (NASDAQ: PRSO) reported a 36% sequential increase in Q2 2026 net revenue to $1.3 million, primarily due to higher mmWave product shipments and the fulfillment of a delayed fixed wireless access order. Despite this growth, revenue was down year-over-year, and the company posted …

Early Alert: PLAG, PRSO, UZX, IGC Lead Sub-$1 Stocks to Watch – Plus More in Focus

This article highlights several sub-$1 and microcap stocks that are attracting investor attention due to recent catalysts. Companies like Planet Green Holdings Corp. (PLAG), Peraso Inc. (PRSO), Linkage Global Inc. (UZX), IGC Pharma, Inc. (IGC), Fort Technology Inc. (FRTT), Algorhythm Holdings, Inc. (RIME), and …

Peraso Announces Second Quarter 2026 Results

Peraso Inc. announced its financial results for the second quarter ended June 30, 2026, with total net revenue reaching $1.3 million, an increase from the prior quarter. The company's CEO, Ron Glibbery, noted that revenue exceeded expectations due to a delayed order shipment, despite …

VSTM Maintains by Mizuho -- Price Target Lowered to $13.00

Mizuho maintained an "Outperform" rating for Verastem (VSTM) but lowered its price target from $14.00 to $13.00, reflecting market sentiment and challenges despite the company's focus on novel anticancer agents. Verastem's GF Score™ of 14/100 highlights significant financial and profitability struggles, with insider activity …

Mizuho lowers Verastem stock price target on valuation to $13

Mizuho has lowered its price target for Verastem Inc. (NASDAQ:VSTM) to $13 from $14, while maintaining an Outperform rating, following strong Q2 2026 results that surpassed analyst expectations. The company reported significant revenue growth, a high gross profit margin, and secured new financing, extending …

Peraso Targets Defense and UAV Markets with New PRM2145 Jam-Resistant Communications Module

Peraso Inc. has introduced the PRM2145, a new wireless communications module designed for unmanned aerial vehicles (UAVs), autonomous systems, and defense applications. This module uses 60 GHz mmWave technology to provide secure, low-latency, gigabit-class communications with enhanced resistance to jamming, addressing the growing demand …

Mizuho Adjusts Price Target on Verastem to $13 From $14, Keeps Outperform Rating

Mizuho Securities has lowered its price target for Verastem (VSTM) to $13 from $14, while maintaining an Outperform rating on the stock. According to analysts, Verastem currently holds an average "buy" rating with a mean price target of $14.75. Access to the full MT …

Jerash Holdings (US) Inc (JRSH) (Q1 2027) Earnings Call Highlights: Record Revenue and Fivefold ...

Jerash Holdings (US) Inc (JRSH) reported record fiscal Q1 2027 revenue of $50.2 million, a 26.7% increase year-over-year, with net income surging more than fivefold to $1.7 million. This growth was driven by higher shipments to major US customers and the strategic partner Hanson …

Jerash Holdings (US) Q1 Earnings Call Highlights

Key Points Interested in Jerash Holdings (US), Inc.? Here are five stocks we like better. Strong Q1 fiscal 2027 results: Revenue increased 26.7% to $50.2 million, gross margin expanded to 16.4%, and net income more than quintupled to $1.7 million, or $0.13 per diluted …

Peraso announces annual shareholder meeting

Peraso will conduct its annual stockholder meeting virtually on September 10, 2026. Shareholders will vote on the election of four directors, the expansion of the 2019 stock incentive plan by 1.5 million shares, and an advisory vote on executive pay. Other items include a …

Peraso launches wireless module for defense, UAV applications

Peraso Inc. (NASDAQ:PRSO) has announced the launch of PRM2145, a new wireless communications module specifically designed for defense, UAV, and autonomous systems applications. This module leverages 60 GHz millimeter wave technology to provide gigabit-class wireless throughput and ultra-low-latency communications for airborne platforms. The PRM2145 …

Peraso launches wireless module for drone communications

Peraso Inc. has introduced the PRM2145, a new wireless communications module designed for unmanned aerial vehicles, autonomous systems, and defense communications. This module utilizes 60 GHz millimeter wave technology to provide high-throughput, low-latency communication with beamforming capabilities, making it suitable for challenging radio frequency …